tradingkey.logo

Becton Dickinson and Co

BDX
View Detailed Chart

206.990USD

+0.550+0.27%
Close 04/30, 16:00ETQuotes delayed by 15 min
59.43BMarket Cap
34.41P/E TTM

Becton Dickinson and Co

206.990

+0.550+0.27%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.27%

5 Days

+2.31%

1 Month

-9.64%

6 Months

-11.39%

Year to Date

-8.76%

1 Year

-11.77%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 17 analysts
BUY
Current Rating
270.036
Target Price
30.81%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

111
Total
7
Median
9
Average
Company name
Ratings
Analysts
Becton Dickinson and Co
BDX
17
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
28
Dexcom Inc
DXCM
26
1
2
3
...
22

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Neutral
Sell(4)
Neutral(2)
Buy(6)
Indicators
Sell(1)
Neutral(2)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
2.192
Neutral
RSI(14)
44.932
Neutral
STOCH(KDJ)(9,3,3)
80.854
Buy
ATR(14)
6.323
Low Volatility
CCI(14)
102.659
Buy
Williams %R
20.745
Buy
TRIX(12,20)
-0.461
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
204.584
Buy
MA10
202.056
Buy
MA20
206.191
Buy
MA50
219.011
Sell
MA100
225.399
Sell
MA200
230.056
Sell

News

More news coming soon, stay tuned...

Company

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company codeBDX
CompanyBecton Dickinson and Co
CEOMr. Thomas E. Polen
Websitehttps://www.bd.com/